The DOI matches its Crossref record.
CD79: A Review
Abstract
CD79 is composed of CD79a and CD79b components expressed almost exclusively on B cells and B-cell neoplasms. CD79a and CD79b expression precedes immunoglobulin (Ig) heavy-chain gene rearrangement and CD20 expression during B-cell ontogeny and disappears later than CD20 in the late (plasma cell) stage of B-cell differentiation. Therefore, antibodies to CD79a and CD79b are useful in the differential diagnosis of B-cell neoplasms from T-cell neoplasms or myeloid neoplasms, or L and H lymphocyte predominance Hodgkin's lymphoma from classic Hodgkin's lymphoma. In addition, CD79a and CD79b antibodies are useful markers in the diagnosis of precursor B-acute lymphoblastic leukemia (pre-B-ALL) because many of these tumors are negative for other B-cell markers, such as CD20 and CD45RA. Furthermore, for B-cell neoplasms, wherein CD20 expression is aberrantly lost, such as in diffuse large B-cell lymphoma, or for B-cell neoplasms after CD20-antibody therapy, CD79a may be used as a first-line B-cell marker for the diagnosis. In this review, the authors discuss the molecular biology of CD79 and the frequency and usefulness of CD79 expression in these neoplasms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 78
- Wienands, 2000, Curr Top Microbiol Immunol, 245, 53
- Van Noesel, 2000, J Immunol, 146, 3881, 10.4049/jimmunol.146.11.3881 · DOI
- Mason, 1995, Blood, 861453-, 9
- Mason, 1992, Eur J Immunol, 22, 2753, 10.1002/eji.1830221044 · DOI
- Zomas, 1996, Leukemia, 10, 1966
- Moreau, 1997, Am J Clin Pathol, 108, 378, 10.1093/ajcp/108.4.378 · DOI
- Astsaturov, 1996, Leukemia, 10, 769
- Buccheri, 1993, Blood, 82, 853, 10.1182/blood.V82.3.853.bloodjournal823853 · DOI
- Kurtin, 1999, Am J Clin Pathol, 112, 319, 10.1093/ajcp/112.3.319 · DOI
- Geisler, 1991, Blood, 78, 1795, 10.1182/blood.V78.7.1795.1795 · DOI · Paper page
- Yu, 1992, J Immunol, 148, 633, 10.4049/jimmunol.148.2.633 · doi:10.4049/jimmunol.148.2.633
- Ha, 1992, J Immunol, 148, 1526, 10.4049/jimmunol.148.5.1526 · doi:10.4049/jimmunol.148.5.1526
- Ha, 1994, J Immunol, 152, 5749, 10.4049/jimmunol.152.12.5749 · doi:10.4049/jimmunol.152.12.5749
- Hashimoto, 1994, Immunogenetics, 40, 145
- Wood, 1993, Genomics, 16, 187, 10.1006/geno.1993.1157 · doi:10.1006/geno.1993.1157
- Muller, 1992, Eur J Immunol, 22, 1621, 10.1002/eji.1830220641 · doi:10.1002/eji.1830220641
- Bennani-Baiti, 1998, Genomics, 48, 258, 10.1006/geno.1997.5171 · doi:10.1006/geno.1997.5171
- Van Noesel, 1992, J Exp Med, 175, 1511, 10.1084/jem.175.6.1511 · DOI
- Hombach, 1990, Nature, 343, 760, 10.1038/343760a0 · DOI · Paper page
- Kim, 1993, Eur J Immunol, 23, 911, 10.1002/eji.1830230422 · DOI
- Gold, 1991, Proc Natl Acad Sci U S A, 88, 3436, 10.1073/pnas.88.8.3436 · DOI · Paper page
- Reth, 1995, Immunol Today, 16, 310, 10.1016/0167-5699(95)80141-3 · doi:10.1016/0167-5699(95)80141-3
- Brouns, 2000, Int Immunol, 7, 359, 10.1093/intimm/7.3.359 · doi:10.1093/intimm/7.3.359
- Pleiman, 1994, Proc Natl Acad Sci U S A, 91, 4268, 10.1073/pnas.91.10.4268 · DOI
- Lin, 1992, J Immunol, 149, 1548, 10.4049/jimmunol.149.5.1548 · DOI
- Minegishi, 1999, J Clin Invest, 104, 1115, 10.1172/JCI7696 · DOI · Paper page
- Gong, 1996, Science, 272, 411, 10.1126/science.272.5260.411 · DOI · Paper page
- Torres, 1996, Science, 272, 1802, 10.1126/science.272.5269.1804 · DOI · Paper page
- Nagata, 1997, Immunity, 7, 559, 10.1016/S1074-7613(00)80377-5 · DOI
- Tseng, 1997, Blood, 89, 1513, 10.1182/blood.V89.5.1513.1513_1513_1520 · doi:10.1182/blood.v89.5.1513.1513_1513_1520
- Bonnerot, 1995, Immunity, 3, 335, 10.1016/1074-7613(95)90118-3 · DOI
- Patel, 1993, Cell, 74, 939, 10.1016/0092-8674(93)90473-4 · DOI
- Mason, 1991, J Immunol, 147, 2474, 10.4049/jimmunol.147.8.2474 · DOI
- Bhargava, 2000, Mod Pathol, 13, 143A
- Vasile, 1994, Mol Immunol, 31, 419, 10.1016/0161-5890(94)90061-2 · DOI
- Nakamura, 1992, Proc Natl Acad Sci U S A, 89, 8522, 10.1073/pnas.89.18.8522 · DOI
- Koyama, 1997, Int Immunol, 9, 1767, 10.1093/intimm/9.11.1767 · DOI
- Dworzak, 1998, Blood, 92, 3203, 10.1182/blood.V92.9.3203 · doi:10.1182/blood.v92.9.3203
- Li, 1993, J Exp Med, 178, 951, 10.1084/jem.178.3.951 · DOI · Paper page
- Verschuren, 1993, Leukemia, 7, 1939
- Pezzella, 2000, Br J Haematol, 108, 369, 10.1046/j.1365-2141.2000.01844.x · doi:10.1046/j.1365-2141.2000.01844.x
- Kanavaros, 1995, Am J Pathol, 146, 735
- Cerroni, 1997, Am J Surg Pathol, 21, 1307, 10.1097/00000478-199711000-00005 · DOI
- Chang, 1996, Appl Immunohistochem, 4, 1
- Weiss, 1993, Appl Immunohistochem, 1, 166
- Chuang, 1997, Am J Clin Pathol, 107, 410, 10.1093/ajcp/107.4.410 · DOI
- Mori, 1994, Virchows Arch, 424, 553
- Grillo-Lopez, 1999, Semin Oncol, 26, 66
- Chinn, 1999, Int J Oncol, 15, 1017
- Press, 1999, Semin Oncol, 26, 58
- Davis, 1999, Clin Cancer Res, 5, 611
- Garcia Vela, 1999, Leukemia, 13, 1501, 10.1038/sj.leu.2401511 · doi:10.1038/sj.leu.2401511
- Matutes, 1994, Leuk Lymphoma, 14, 57
- Lankester, 1995, Blood, 86, 1090, 10.1182/blood.V86.3.1090.1090 · DOI
- Thompson, 1997, Blood, 90, 1387, 10.1182/blood.V90.4.1387 · DOI
- Alfarano, 1999, Blood, 93, 2327, 10.1182/blood.V93.7.2327 · DOI
- Thompson, 1999, Leuk Lymphoma, 32, 561, 10.3109/10428199909058414 · doi:10.3109/10428199909058414
- Pilozzi, 1998, J Pathol, 186, 140, 10.1002/(SICI)1096-9896(1998100)186:2<140::AID-PATH149>3.0.CO;2-Y · doi:10.1002/(sici)1096-9896(1998100)186:2<140::aid-path149>3.0.co;2-y
- Lai, 2000, Am J Clin Pathol, 113, 823, 10.1309/391R-93YF-DB4D-1L35 · DOI
- Blakolmer, 2000, Mod Pathol, 13, 766, 10.1038/modpathol.3880133 · DOI
- Stein, 1986, Am J Clin Pathol, 86, 292, 10.1093/ajcp/86.3.292 · DOI
- Pinkus, 1988, Am J Pathol, 133, 211
- Korkolopoulou, 1994, Histopathology, 24, 511, 10.1111/j.1365-2559.1994.tb00568.x · doi:10.1111/j.1365-2559.1994.tb00568.x
- Kuzu, 1993, Histopathology, 22, 141, 10.1111/j.1365-2559.1993.tb00092.x · doi:10.1111/j.1365-2559.1993.tb00092.x
- Ashton-Key, 1995, Am J Surg Pathol, 19, 1294, 10.1097/00000478-199511000-00010 · doi:10.1097/00000478-199511000-00010
- Watanabe, 2000, Histopathology, 36, 353, 10.1046/j.1365-2559.2000.00830.x · doi:10.1046/j.1365-2559.2000.00830.x
- Arber, 1996, Appl Immunohistochem, 4, 241
- Menasce, 1999, Histopathology, 34, 391, 10.1046/j.1365-2559.1999.00651.x · doi:10.1046/j.1365-2559.1999.00651.x
- Arber, 1996, Am J Clin Pathol, 106, 462, 10.1093/ajcp/106.4.462 · DOI
- Arber, 1996, Am J Pathol, 149, 1105
- Pileri, 1999, Br J Haematol, 105, 394, 10.1111/j.1365-2141.1999.01366.x · doi:10.1111/j.1365-2141.1999.01366.x
- Chetty, 1997, Hum Pathol, 28, 493, 10.1016/S0046-8177(97)90040-X · doi:10.1016/s0046-8177(97)90040-x
- Lai, 2000, Mod Pathol, 13, 223, 10.1038/modpathol.3880041 · doi:10.1038/modpathol.3880041
- Toth, 1999, J Clin Pathol, 52, 688, 10.1136/jcp.52.9.688 · DOI
- D'Arena, 2000, Hematologica, 85, 556
- Cabezudo, 1999, Hematologica, 84, 413
- Orazi, 1995, Am J Clin Pathol, 104, 413, 10.1093/ajcp/104.4.413 · DOI
- Vasef, 1997, Am J Clin Pathol, 108, 54, 10.1093/ajcp/108.1.54 · doi:10.1093/ajcp/108.1.54
Cited by
Massively parallel digital transcriptional profiling of single cells
Zheng, G. X. Y., Terry, J. M., Belgrader, P., Ryvkin, P., Bent, Z. W., Wilson, R., Ziraldo, S. B., Wheeler, T. D., McDermott, G. P., Zhu, J., et al. (2017) · Nature Communications · doi:10.1038/ncomms14049 · Cited by 7,353
Tolerability and safety of rituximab (MabThera®)
Kimby, E. (2005) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2005.05.007 · Cited by 470
Antibody Drug Conjugates for Cancer Therapy
Polakis, P. (2016) · Pharmacological Reviews · doi:10.1124/pr.114.009373 · Cited by 307
Buhl, T., Sulk, M., Nowak, P., Buddenkotte, J., McDonald, I., Aubert, J., Carlavan, I., Déret, S., Reiniche, P., Rivier, M., et al. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2015.141 · Cited by 278
Nguyen, C. B., Alsøe, L., Lindvall, J. M., Sulheim, D., Fagermoen, E., Winger, A., Kaarbø, M., Nilsen, H., & Wyller, V. B. (2017) · Journal of Translational Medicine · doi:10.1186/s12967-017-1201-0 · Cited by 59
Metadata
- Authors
- Chu, P. G., & Arber, D. A.
- Venue
- Applied Immunohistochemistry & Molecular Morphology
- Published
- 2001-06
- Volume
- 9
- Issue
- 2
- Pages
- 97-106
- ISSN
- 1533-4058 (ISSN-L)
- 1541-2016
- OpenAlex
- W2318459925
- Cited by
- 190
- References
- 0
- FWCI
- 1.87
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: CD79: A Review. https://app.cochat.ai/papers/10.1097/00129039-200106000-00001
- The paper
- Chu, P. G., & Arber, D. A. (2001). CD79: A Review. Applied Immunohistochemistry & Molecular Morphology. https://doi.org/10.1097/00129039-200106000-00001
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.